Item 2.02 Results of Operations and Financial Condition.
On
The information in this Item 2.02 is unaudited and preliminary and does not
present all information necessary for an understanding of the Company's
financial condition as of
Item 7.01 Regulation FD Disclosure.
The disclosure in Item 2.02 above is hereby incorporated by reference into this
Item 7.01. On
Copies of the press release and the slides presented by
The information in this report, including Exhibit 99.1 and Exhibit 99.2 attached hereto, is furnished pursuant to Items 2.02 and 7.01 and shall not be deemed "filed" for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. It may only be incorporated by reference in another filing under the Exchange Act or the Securities Act of 1933, as amended, if such subsequent filing specifically references the information furnished pursuant to Items 2.02 and 7.01 of this report.
Forward-Looking Statements
This Current Report contains forward looking statements. Any statements contained in this Current Report that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "will," "may," "intends," "prepares," "looks," "potential," "possible" and similar expressions are intended to identify forward-looking statements. These forward-looking statements include statements relating to the Company's expected financial results.
These forward-looking statements involve risks and uncertainties, many of which
are beyond the Company's control. Actual results could materially differ from
those stated or implied by these forward-looking statements as a result of such
risks and uncertainties. Known risk factors include the following: the estimates
and judgments the Company makes, or the assumptions on which it relies, in
preparing its consolidated financial statements could prove inaccurate; the
Company's revenues and operating results could fluctuate significantly, which
may adversely affect the Company's stock price; and those risks identified under
the heading "Risk Factors" in the Company's Quarterly Report on Form 10-Q for
the quarter ended
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit Description Number 99.1 Press Release datedJanuary 9, 2023 99.2Sarepta Therapeutics, Inc. Presentation at the 41st Annual J.P. Morgan Healthcare Conference, datedJanuary 9, 2023 104 The cover page from this Current Report on Form 8-K ofSarepta Therapeutics, Inc. , formatted in Inline XBRL and included as Exhibit 101
--------------------------------------------------------------------------------
© Edgar Online, source